newsfilter
← Latest News
GlobeNewswire·

AVEO Oncology Announces Participation at the Cantor Fitzgerald Oncology & HemOnc Conference

BOSTON, Sept. 21, 2022 (GLOBE NEWSWIRE) -- AVEO Oncology (NASDAQ:AVEO), a commercial stage, oncology-focused biopharmaceutical company committed to delivering medicines that provide a better life for patients with cancer, today announced that Michael B